Sandoz has launched the construction of a state-of-the-art biopharmaceutical production center in Lendava, Slovenia, aiming to establish Europe’s most efficient biosimilar manufacturing facility by 2026, creating 330 jobs, advancing sustainable healthcare, and meeting the growing global demand for biologics.